Nov 15, 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), has reported unaudited financial results for its second quarter ended Sept. 30, 2022, as well as recent business highlights. “We have continued to make progress as planned, advancing our clinical pipeline of modified psychedelic-based molecules while also strengthening our drug discovery platform of differentiated preclinical compounds,” said Cybin’s CEO Doug Drysdale. “In addition to our clinical work, we have been actively broadening our robust IP portfolio through securing strategic licensing agreements for preclinical psychedelic-based compounds that will support our ongoing drug development efforts. These recent initiatives will also pave the way for Cybin to continue to pursue the potential creation of safe and effective therapeutics for patients facing the challenges of mental health conditions.”
In addition, the company today announced that it presented a poster highlighting preclinical data for its deuterated psilocybin analog, CYB003, at Neuroscience 2022 hosted by the Society for Neuroscience (“SFN”), taking place Nov. 12-16, 2022, in San Diego, California. “It is exciting to be part of this year’s SFN meeting and showcase CYB003 amongst leading scientists and academics in the area of psychedelic medicine,” said Cybin’s Head of Research & Development Geoff Varty, Ph.D. “Our presentation at Neuroscience 2022 highlighted the findings from our CYB003 preclinical studies. Compared to classical psilocybin, CYB003 has demonstrated less variability in plasma levels, faster onset of action and shorter duration of effect. These potential therapeutic benefits could result in reduced time and resource burden on the health care system and potentially improved scalability and accessibility of treatment.”
To view the full press releases, visit https://ibn.fm/4O8Rm and https://ibn.fm/WQmOd
About Cybin Inc.
Cybin is a leading ethical biopharmaceutical company working with a network of world-class partners and internationally recognized scientists on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. The company is focused on progressing Psychedelics to Therapeutics by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com.
NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
With foreign hotel guest numbers up 12.5% and the UK historically among its leading international markets, Mozambique is emerging as a compelling alternative for British travellers seeking more than the traditional African holiday.
Demonstrations are expected to continue this weekend in Paris and other French cities. Some museums and tourist sites will be closed, and visitors should expect a strong police presence.
This fall, unlike last year, the province is allowing pharmacists to give out COVID-19 shots. But some pharmacists say they are not getting full shipments of the doses they have ordered.
Mit diesem Beitrag halten wir Sie auf dem Laufenden, was Einreisebedingungen und angekündigte Änderungen in Sachen Visa und elektronische Einreiseanmeldungen angeht. The post Neue Einreiseregeln weltweit: Das hat sich aktuell geändert appeared first on Business Traveller.
Where in the UK can you enjoy the best quality of life without paying a fortune? The results are in - and some surprising cities are beating the big-name hotspots
ITA Airways and Archer Aviation are exploring electric air taxi services connecting Italian airports with city centers, promising faster journeys aboard battery-powered aircraft, although certification and launch dates remain unresolved. The post From Airport to Rome’s City Center in 10 Minutes? ITA Airways and Archer Have a Plan appeared first on Business Traveller.
All my seafood haters, rise up! View Entire Post ›
Sports betting businesses in Ontario, Alberta and eventually Quebec could soon be limited by a Senate bill seeking to restrict sports betting ads across Canada based on findings of increased addiction and gambling-related harms and suicides in Ontario, which reached committee on Wednesday.
Whether you're catching a flight or going on a road trip, these products will help you stay organized. View Entire Post ›
With the spooky season around the corner, ghost tours and Halloween experiences are set to take centre stage. But according to Bókun, a Tripadvisor company, growing interest in dark tourism is helping fuel demand for ghostly experiences year-round. To explore how rising global fascination with the supernatural is translating into year-round bookings, Bókun has shared insights from tour operators, alongside data revealing growing demand for people booking spooky tours on their own doorstep.
The new V&A Waterfront hotel brings 142 rooms, rooftop dining, and contemporary design to South Africa's historic harbour The post EDITION Hotels Expands into Africa, Launching on Cape Town’s V&A Waterfront appeared first on Business Traveller.
November promises to be a remarkably busy month for K-drama fans, offering a wealth of choices that include the year’s biggest fantasy epic and two sequel seasons to recent hits. Here is what to watch over the coming month. 1. The Remarried Empress Lead cast: Shin Min-a, Ju Ji-hoon, Lee Jong-suk, Lee Se-young November’s splashiest show is undoubtedly the big-budget adaptation of the fantasy romance webtoon The Remarried Empress. Shin Min-a plays Navier, the beautiful empress of the Eastern...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.